title: The preferred route for the degradation of silencing target RNAs in transgenic plants depends on pre-established silencing conditions.
abstract: RNA silencing can be initiated upon dsRNA accumulation and results in homology-dependent degradation of target RNAs mediated by 21-23 nt small interfering RNAs (siRNAs). These small regulatory RNAs can direct RNA degradation via different routes such as the RdRP/Dicer- and the RNA-induced silencing complex (RISC)-catalysed pathways. The relative contribution of both pathways to degradation of target RNAs is not understood. To gain further insight in the process of target selection and degradation, we analysed production of siRNAs characteristic for Dicer-mediated RNA degradation during silencing of mRNAs and chimeric viral RNAs in protoplasts from plants of a transgenic tobacco silencing model line. We show that small RNA accumulation is limited to silencing target regions during steady-state mRNA silencing. For chimeric viral RNAs, siRNA production appears dependent on pre-established cellular silencing conditions. The observed siRNA accumulation profiles imply that silencing of viral target RNAs in pre-silenced protoplasts occurs mainly via a RISC-mediated pathway, guided by (pre-existing) siRNAs derived from cellular mRNAs. In cells that are not silenced at the time of infection, viral RNA degradation seems to involve Dicer action directly on the viral RNAs. This suggests that the silencing mechanism flexibly deploys different components of the RNA degradation machinery in function of the prevailing silencing status.
authors.affiliation: Unit of Molecular Signal Transduction in Inflammation, Department for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology (VIB), Ghent University, Technologiepark 927, B-9052 Gent, Zwijnaarde, Belgium. matthews@dmbr.ugent.be
authors.forename: Matthew
authors.initials: M
authors.lastname: Sanders
authors.forename: Nausicaa
authors.initials: N
authors.lastname: Lannoo
authors.forename: Wendy
authors.initials: W
authors.lastname: Maddelein
authors.forename: Anna
authors.initials: A
authors.lastname: Depicker
authors.forename: Marc
authors.initials: M
authors.lastname: Van Montagu
authors.forename: Marc
authors.initials: M
authors.lastname: Cornelissen
authors.forename: John
authors.initials: J
authors.lastname: Jacobs
mesh_terms: D002460:Cell Line; D043326:Glucan 1,3-beta-Glucosidase / Q000235:genetics / Q000378:metabolism; D030821:Plants, Genetically Modified; D011523:Protoplasts / Q000378:metabolism; D034622:RNA Interference; D012333:RNA, Messenger / Q000737:chemistry / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000096:biosynthesis*; D012367:RNA, Viral / Q000235:genetics / Q000378:metabolism; D034743:RNA-Induced Silencing Complex / Q000378:metabolism; D043244:Ribonuclease III / Q000378:metabolism; D014026:Nicotiana / Q000166:cytology / Q000235:genetics*
chemical_list: D012333:RNA, Messenger; D034741:RNA, Small Interfering; D012367:RNA, Viral; D034743:RNA-Induced Silencing Complex; D043244:Ribonuclease III; D043326:Glucan 1,3-beta-Glucosidase